| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/25/2001 | WO2001036662A2 Hydrolytic enzyme substrates and assay method |
| 05/25/2001 | WO2001036661A2 Method and apparatus for prokaryotic and eukaryotic cell quantitation |
| 05/25/2001 | WO2001036659A2 Selectable cell surface marker genes |
| 05/25/2001 | WO2001036658A2 Method for evaluating states of biological systems |
| 05/25/2001 | WO2001036641A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 05/25/2001 | WO2001036640A2 Human fgf-21 gene and gene expression products |
| 05/25/2001 | WO2001036639A2 Bt toxin receptors from lepidopteran insects and methods of use |
| 05/25/2001 | WO2001036638A2 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036634A1 Novel g protein-coupled receptors, genes thereof and production and use of the same |
| 05/25/2001 | WO2001036624A1 High order nucleic acid based structures |
| 05/25/2001 | WO2001036613A1 Blood-compatible polymer surfaces |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036602A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 05/25/2001 | WO2001036589A2 Human ex vivo immune system |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036486A2 Scfv antibodies against disease associated molecules |
| 05/25/2001 | WO2001036485A2 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors |
| 05/25/2001 | WO2001036484A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | WO2001036479A1 G-protein coupled receptor |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001036475A2 Biglycan and related therapeutics and methods of use |
| 05/25/2001 | WO2001036474A2 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | WO2001036472A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036470A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 05/25/2001 | WO2001036461A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036453A2 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 05/25/2001 | WO2001036449A1 Multi-compartment electrophoresis |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036073A1 Rapid protein identification using antibody mixtures |
| 05/25/2001 | WO2001036005A2 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | WO2001035995A2 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | WO2001035986A2 Methods and compositions for modulating er-stress-induced cholesterol accumulation |
| 05/25/2001 | WO2001035980A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 05/25/2001 | WO2001035903A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001035820A1 Tissue interface device |
| 05/25/2001 | WO2001035811A2 Methods of diagnosing and determining prognosis of breast cancer |
| 05/25/2001 | WO2001035759A1 Sperm cell selection system |
| 05/25/2001 | WO2001035728A1 Mastitis detection |
| 05/25/2001 | WO2001035720A1 Constituent sensing system |
| 05/25/2001 | WO2001007159A3 Integration of biochemical protocols in a continuous flow microfluidic device |
| 05/25/2001 | WO2001006005A3 Diagnostic method comprising wt1 sequences |
| 05/25/2001 | WO2001004349A3 Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease |
| 05/25/2001 | WO2001004141A3 Seripancrin |
| 05/25/2001 | WO2001002828A3 Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides |
| 05/25/2001 | WO2000079273A3 Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample |
| 05/25/2001 | WO2000078362A3 Stable, radioactively marked nanoparticles, method for the production and utilization thereof |
| 05/25/2001 | WO2000078330A3 Adenosine diphosphatase and activators thereof and their medical uses |
| 05/25/2001 | WO2000077251A3 Forensic dna profiling method comprising immunological separation step |
| 05/25/2001 | WO2000075654A3 Mastitis detection method |
| 05/25/2001 | WO2000075278A3 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 05/25/2001 | WO2000075190A3 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 05/25/2001 | WO2000073345A3 Antibodies specific for mycobacterial polypeptides and uses thereof |
| 05/25/2001 | WO2000073338A8 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 05/25/2001 | WO2000067793A8 Death domain containing receptor 4 |
| 05/25/2001 | WO2000064469A3 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 05/25/2001 | WO2000061814A8 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
| 05/25/2001 | WO2000047750B1 Metalloproteases of the neprilysin family |
| 05/25/2001 | WO2000010588A3 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 05/25/2001 | WO1999063087A8 G-protein coupled receptor, named 2871 receptor |
| 05/25/2001 | CA2794123A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2738796A1 Biglycan and uses thereof in stabilizing dystrophin associated protein complexes |
| 05/25/2001 | CA2732120A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | CA2483352A1 Inhibitors of endo-exonuclease activity for treating cancer |
| 05/25/2001 | CA2427106A1 Method and apparatus for prokaryotic and eukaryotic cell quantitation |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392258A1 Compact optical probe and related measuring method |
| 05/25/2001 | CA2392103A1 Human fgf-21 gene and gene expression products |
| 05/25/2001 | CA2392090A1 G-protein coupled receptor |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | CA2391998A1 Method for assessing genotoxicity of a compound |
| 05/25/2001 | CA2391925A1 Antibodies |
| 05/25/2001 | CA2391885A1 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391875A1 Methods and compositions for modulating er-stress-induced cholesterol accumulation |
| 05/25/2001 | CA2391743A1 Apparatus and method for assaying coagulation in fluid samples |
| 05/25/2001 | CA2391593A1 Selectable cell surface marker genes |
| 05/25/2001 | CA2391558A1 Immunological detection of rna:dna hybrids on microarrays |
| 05/25/2001 | CA2391531A1 Placental human neurokinin b precursor |
| 05/25/2001 | CA2391530A1 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | CA2391504A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | CA2391450A1 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | CA2391212A1 Methods and compositions for identifying disease markers |
| 05/25/2001 | CA2391084A1 High order nucleic acid based structures |
| 05/25/2001 | CA2390607A1 Materials and methods for detection and treatment of breast cancer |
| 05/25/2001 | CA2390548A1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | CA2390499A1 Constituent sensing system |
| 05/25/2001 | CA2390051A1 Thymidylate synthase polymorphism for predicting chemotherapeutic response |
| 05/25/2001 | CA2390031A1 Double-stranded rna receptor (dsrna-r) and methods relating thereto |
| 05/25/2001 | CA2389851A1 Human igm antibodies to chemokine receptors |
| 05/25/2001 | CA2389430A1 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | CA2389289A1 Mammalian toxicological response markers |
| 05/25/2001 | CA2388922A1 23 human secreted proteins |
| 05/25/2001 | CA2388904A1 Hydrolytic enzyme substrates and assay method |
| 05/25/2001 | CA2388703A1 Long oligonucleotide arrays |
| 05/25/2001 | CA2388563A1 Diagnosis kit, method and microarray for determining human detoxification capacity |
| 05/25/2001 | CA2359577A1 Antibodies and fv fragment recognizing antigen ior c2 |
| 05/24/2001 | US20010001800 The xanthene compound reacts with nitric oxide to give a triazole fluorescent compound that emits strong fluorescence by irradiation with excitation light of long wavelength |
| 05/24/2001 | US20010001713 Comprising said agrochemical and Congo Red as a tracer |
| 05/24/2001 | US20010001708 Comprising degradative glucanase enzyme specific for heparin and stabilizer; useful in substantially neutralizing residual heparin from a blood sample when used in a blood collection tube without interfering with clinical analysis |